Sara Morrow
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
-
- T-cell and Retrovirus Studies
Papers in
-
- Protein Degradation and Inhibitors 2
- Genetics 6
- Glioma Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- David M. Weinstock (5 shared papers)Raphael Koch (2 shared papers)Steven M. Horwitz (1 shared paper)Katherine A. Donovan (2 shared papers)Jennifer Sweeney (1 shared paper)Eric S. Fischer (2 shared papers)Steven P. Treon (2 shared papers)Patricia L. Myskowski (1 shared paper)
- Journals
- Blood (4 papers)Cancer Research (3 papers)Neuro-Oncology (2 papers)Cancer Discovery (1 paper)Toxicology Reports (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Sara Morrow
13 papers receiving 517 citations
Peers
Comparison fields: 5 of 59
- Genetics 103
- Immunology 203
- Pathology and Forensic Medicine 166
- Oncology 243
- Dermatology 77
Countries citing papers authored by Sara Morrow
This map shows the geographic impact of Sara Morrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Morrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Morrow more than expected).
Fields of papers citing papers by Sara Morrow
This network shows the impact of papers produced by Sara Morrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Morrow. The network helps show where Sara Morrow may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Morrow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 204 | |
| 2 | 2018 | 131 | |
| 3 | 2019 | 110 | |
| 4 | 2018 | 35 | |
| 5 | 2018 | 18 | |
| 6 | 2018 | 12 | |
| 7 | 2021 | 3 | |
| 8 | A survey of school counselor attitudes regarding animal-assisted interventions | 2009 | 2 |
| 9 | 2018 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 1 |
About Sara Morrow
Sara Morrow is a scholar working on Molecular Biology, Genetics, Pathology and Forensic Medicine, Immunology and Neurology, having authored 13 papers that have together received 522 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Protein Degradation and Inhibitors (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Neuroblastoma Research and Treatments (2 papers), Cytokine Signaling Pathways and Interactions (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Genetics (103 citations), Immunology (203 citations), Pathology and Forensic Medicine (166 citations), Oncology (243 citations) and Dermatology (77 citations). Sara Morrow has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include David M. Weinstock, Raphael Koch, Steven M. Horwitz, Katherine A. Donovan, Jennifer Sweeney, Eric S. Fischer, Steven P. Treon, Patricia L. Myskowski, Megan N. Perez and Alison J. Moskowitz. Their work appears in journals such as Blood, Cancer Research, Neuro-Oncology, Cancer Discovery and Toxicology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.